Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Matinas BioPharma Announces Positive In vivo Safety Data With Its Oral LNC-Docetaxel Formulation

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    25/03/2024 13:42
    March 25 (Reuters) - Matinas BioPharma Holdings Inc
 MTNB.A :
    * MATINAS BIOPHARMA ANNOUNCES POSITIVE IN VIVO SAFETY DATA
WITH
ITS ORAL LNC-DOCETAXEL FORMULATION

Source text for Eikon:  ID:nGNX9qYfZJ 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Matinas BioPharma Holdings

    See all news